Unicycive Therapeutics, Inc. (UNCY) News https://ir.unicycive.com/news/rss en-us https://d1io3yog0oux5.cloudfront.net/unicycive/files/theme/images/logo-email.png Unicycive Therapeutics, Inc. Logo Equisolve Investor Relations Suite <![CDATA[Unicycive Therapeutics to Present at the 25th Annual Needham Virtual Healthcare Conference]]> https://ir.unicycive.com/news/detail/121/unicycive-therapeutics-to-present-at-the-25th-annual Thu, 09 Apr 26 07:05:00 -0400 https://ir.unicycive.com/news/detail/121/unicycive-therapeutics-to-present-at-the-25th-annual <![CDATA[Unicycive Therapeutics Announces Full Year 2025 Financial Results and Provides Business Update]]> https://ir.unicycive.com/news/detail/120/unicycive-therapeutics-announces-full-year-2025-financial Mon, 30 Mar 26 07:05:00 -0400 https://ir.unicycive.com/news/detail/120/unicycive-therapeutics-announces-full-year-2025-financial <![CDATA[Unicycive Therapeutics to Participate in a Fireside Chat at Guggenheim’s Emerging Outlook: Biotech Summit]]> https://ir.unicycive.com/news/detail/119/unicycive-therapeutics-to-participate-in-a-fireside-chat-at Wed, 04 Feb 26 07:05:00 -0500 https://ir.unicycive.com/news/detail/119/unicycive-therapeutics-to-participate-in-a-fireside-chat-at <![CDATA[UPDATE - Unicycive Therapeutics Announces FDA Acceptance of Oxylanthanum Carbonate (OLC) New Drug Application (NDA) Resubmission]]> https://ir.unicycive.com/news/detail/118/update---unicycive-therapeutics-announces-fda-acceptance-of Thu, 29 Jan 26 09:15:00 -0500 https://ir.unicycive.com/news/detail/118/update---unicycive-therapeutics-announces-fda-acceptance-of <![CDATA[Unicycive Therapeutics Announces FDA Acceptance of Oxylanthanum Carbonate (OLC) New Drug Application (NDA) Resubmission]]> https://ir.unicycive.com/news/detail/117/unicycive-therapeutics-announces-fda-acceptance-of Thu, 29 Jan 26 07:05:00 -0500 https://ir.unicycive.com/news/detail/117/unicycive-therapeutics-announces-fda-acceptance-of <![CDATA[Unicycive Therapeutics Announces Resubmission of New Drug Application (NDA) for Oxylanthanum Carbonate (OLC)]]> https://ir.unicycive.com/news/detail/116/unicycive-therapeutics-announces-resubmission-of-new-drug Mon, 29 Dec 25 07:05:00 -0500 https://ir.unicycive.com/news/detail/116/unicycive-therapeutics-announces-resubmission-of-new-drug <![CDATA[Unicycive Therapeutics to Participate in Upcoming Investor Events in December]]> https://ir.unicycive.com/news/detail/115/unicycive-therapeutics-to-participate-in-upcoming-investor Tue, 25 Nov 25 07:05:00 -0500 https://ir.unicycive.com/news/detail/115/unicycive-therapeutics-to-participate-in-upcoming-investor <![CDATA[Unicycive Therapeutics Announces Third Quarter 2025 Financial Results and Provides Business Update]]> https://ir.unicycive.com/news/detail/114/unicycive-therapeutics-announces-third-quarter-2025 Wed, 12 Nov 25 07:05:00 -0500 https://ir.unicycive.com/news/detail/114/unicycive-therapeutics-announces-third-quarter-2025 <![CDATA[Unicycive Therapeutics to Participate in a Fireside Chat at the Guggenheim 2nd Annual Healthcare Innovation Conference]]> https://ir.unicycive.com/news/detail/113/unicycive-therapeutics-to-participate-in-a-fireside-chat-at Mon, 03 Nov 25 07:05:00 -0500 https://ir.unicycive.com/news/detail/113/unicycive-therapeutics-to-participate-in-a-fireside-chat-at <![CDATA[Unicycive Therapeutics Announces Upcoming Presentation of New Data Reinforcing the Potential of Oxylanthanum Carbonate for the Treatment of Hyperphosphatemia at the American Society of Nephrology Kidney Week 2025 Conference]]> https://ir.unicycive.com/news/detail/112/unicycive-therapeutics-announces-upcoming-presentation-of Thu, 30 Oct 25 07:05:00 -0400 https://ir.unicycive.com/news/detail/112/unicycive-therapeutics-announces-upcoming-presentation-of